This nationwide, register-based, matched-cohort study evaluates the potential association between fluconazole exposure during pregnancy and risk of spontaneous abortion and stillbirth among women in Denmark.
This retrospective study compared risk of death among Medicaid patients in Tennessee initiating long-acting opioid therapy for chronic noncancer pain with patients taking anticonvulsants or cyclic antidepressants.
This Medical Letter review summarizes several opioid formulations that claim to deter abuse.
This randomized trial compared improvement in functional outcomes among patients with low back pain discharged from the emergency department and receiving naproxen with either placebo, cyclobenzaprine, or oxycodone/acetaminophen.
Raebel and colleagues compare use of opioid medications for chronic pain 1 year before bariatric surgery vs 1 year after in a retrospective cohort study of 11 719 US patients from 2005 through 2009. In an Editorial, Alford discusses risks associated with opioid use and decreasing the need for chronic opioid therapy.
This study analyzed the dose accuracy of labels from edibile medical cannabis products dispensed in 3 US cities.
Warner and coauthors conducted a retrospective cohort study of 44 612 physicians in anesthesiology residency programs to describe the incidence and outcomes of substance use disorder among a subset of US physicians.
This Viewpoint describes the benefits of, evidence behind, and prescriber concerns with mandates, and recommends policies that may increase effective use of prescription drug monitoring programs.
Saitz and coauthors conducted a randomized trial among 563 people with alcohol and other drug dependence to investigate whether chronic care management improves substance use outcomes compared with usual primary care. O’Connor comments in an editorial.
This randomized clinical trial compares the efficacy and adverse events of house dust mite sublingual allergen immunotherapy vs placebo for asthma exacerbations in adults with allergic asthma during an inhaled corticosteroid reduction period.